Peminda Cabandugama, MD

Appointed
2022

Education & Fellowships

Fellowship - University of Missouri
Endocrinology, Diabetes & Metabolism (IM)
Columbia, MO United States
2017

Residency - Woodhull Medical & Mental Health Center
Internal Medicine
Brooklyn, NY
2015

Medical Education - St George's University School of Medicine
Grenada West Indies, Grenada
2011

Undergraduate - Winona State University
Double Major: Cell and Molecular Biology/Allied Health, Minor: Biochemistry
Winona, MN United States
2006

Additional Training

Professional Highlights

• Chair-Elect, Clinical Practice Section, The Obesity Society (TOS), 2024-present
• Director of Digital Obesity, Cleveland Clinic, Cleveland OH, 2022-present
• Faculty, Obesity Fellowship, Cleveland Clinic, Cleveland OH, 2022-present
• Vice President, Midwest Obesity Society, 2019-2023
• Member of The Obesity Society (TOS) Spokesperson Network, 2021-present
• Member of Obesity Medical Association (OMA) Outreach Committee, 2021-2023 
• Member of Advisory Board, Midwest Obesity Society, 2018-present 
• Member of the American Board of Obesity Medicine (ABOM) Item Writing Committee, 2021-2022
• Associate Program Director, Endocrine Fellowship Program, University of Missouri- Kansas City School of Medicine, 2017-2019

Certifications

• Internal Medicine - Endocrinology, Diabetes and Metabolism
• Obesity Medicine
• Internal Medicine

Specialty Interests

Weight Management -Diabetes Mellitus Type 2/Type 1 (non-pump) -Hypothyroidism/Hyperthyroidism -Thyroid disease with pregnancy

Awards & Honors

• Excellence in Teaching Award-Best Endocrinology Teaching Faculty for UMKC Endocrinology Fellowship Program 2020-2021; University of Missouri-Kansas City
• Excellence in Teaching Award- Top 10% of Teaching Faculty for UMKC Internal Medicine Residency Program 2020-2021; University of Missouri-Kansas City
• Recipient- Golden Key International Honors (2006)
• Recipient-Tri-beta Honors (2006)Recipient-Dr. E. W. Haesley Scholarship for exceptional promise as a Pre-Medical Student (2005)

Innovations & Patents

Memberships

• Midwest Obesity Society (Founding Member)
• American Board of Obesity Medicine (ABOM)
• The Obesity Society (TOS)
• Obesity Medical Association (OMA)
• Endocrine Society
• American Association of Clinical Endocrinology (AACE)
• American Board of Internal Medicine (ABIM)
• Committee of Interns and Residents (CIR)
• Golden Key International Honor Society
• Tri-beta Honor Society, Winona State University, MN

See publications for Peminda Cabandugama, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/26/2024, Dr. Cabandugama has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.